Speaking on December 22, 2020 to the German media, CEO of BioNTech, Ugur Sahin expressed confidence that the vaccine his company created in partnership with American company Pfizer, is able to inoculate against the new strains of the coronavirus that have surfaced in the UK, Australia, Denmark, the Netherlands and also South Africa.
Sahin revealed that the UK variant's proteins are 99 per cent the same as the prevailing strains, and therefore BioNTech has “scientific confidence” that its vaccine will be effective.
